Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.
about
Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studies2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summaryA systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.Multisite quantitative ultrasound for the prediction of fractures over 5 years of follow-up: the Canadian Multicentre Osteoporosis Study.Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.Screening, assessment, and treatment of osteoporosis for the nurse practitioner: key questions and answers for clinical practice--a Canadian perspectivePerformance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic reviewFragility fracture: recent developments in risk assessment.A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy.A practical approach to osteoporosis management in the geriatric populationEstimating osteoporotic fracture risk following a wrist fracture: a tale of two systems.Recommendations for preventing fracture in long-term care.Bone Mineral Density Reporting Underestimates Fracture Risk in OntarioWhat Do We Know about Individuals Who Are Assessed as Being at Moderate Risk for Future Fracture in Canada?Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial.An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures.Ankle fractures do not predict osteoporotic fractures in women with or without diabetesOsteoporosis Canada 2010 guidelines for the assessment of fracture risk.Osteoporosis prescribing in long-term care: impact of a provincial knowledge translation strategy.Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos).Fracture risk assessment after BMD examination: whose job is it, anyway?Comparison between various fracture risk assessment tools.Bone health care for patients with prostate cancer receiving androgen deprivation therapy.Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program.Patient perceptions of provider barriers to post-fracture secondary prevention.Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?Agreement between fragility fracture risk assessment algorithms as applied to adults with chronic spinal cord injury.Does osteoporosis therapy invalidate FRAX for fracture prediction?Competing mortality and fracture risk assessment.Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) study.Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.Measuring improvement in fracture risk prediction for a new risk factor: a simulation.Direct comparison of FRAX(R) and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.A comparative study of using non-hip bone density inputs with FRAX®.Recommandations en vue de la prévention des fractures dans les établissements de soins de longue durée.Les bisphosphonates dans le traitement de l’ostéoporose: Bienfaits attendus, torts potentiels et congés thérapeutiques.Assessment of Fracture Risk
P2860
Q26853714-AEDB7C35-4E2B-4961-99D1-CD809B1E80F9Q28295416-16248E77-2A3E-4F3C-A947-BBD8F3C8D95FQ30248756-6315F683-A7D5-4113-9E58-E76F7C91E785Q30370578-3DD6E98A-3B9F-48AC-AA0A-8B21A99F0277Q33715141-ED3C6615-6418-45AF-830E-4A563DA7EAA4Q34074981-D1A6545F-D1EB-40E2-BA36-E601C92C61E1Q35012083-04D1B6EB-2234-4A31-A677-3E9DA43D159FQ35039567-2F6DC40A-0149-4F14-9A0C-334F5ACFA421Q35145672-44F21824-07F3-44E7-BB57-DFE864546267Q35223327-319405AD-41B2-42C3-A381-63DF1277AD81Q36013092-C2FA761A-E6E0-4581-A404-3DBF99D05990Q36176941-09FCCBAA-E1B7-4050-A9C4-382A49C99445Q36217195-B4842456-6E85-4242-8FA3-51C628538F36Q36217203-5A86B6EA-DFF9-41A6-93BB-F6C9ED705D4EQ36588456-5EE15813-0516-4D27-A1CE-213DD4433B3FQ36631752-A437408B-353B-4BEE-983F-EDCFF81B8C51Q37401888-C9577D64-CEFA-455B-9757-F21B0640D894Q37401890-1138C0AE-6BC5-4D0F-B912-F640F9A2A371Q37407718-8B0897E8-BD93-48CB-815F-6804FBD89463Q37418453-690A85F6-90B8-4CDE-9F33-5DF47AFE3D36Q37705681-7D5F5508-DFEE-4EDE-B0EE-24BCF18EC6BEQ38116795-91BACF1D-BB9B-49BB-AA41-7105E7A25484Q38207463-88CD8B61-542D-4CDF-85ED-722D550CC042Q38558916-19A43074-8493-4F5B-B1DF-C95C7A213A7FQ38990989-65188926-87AD-4A49-A50C-FF8E62E72284Q39150150-94CF5313-8A55-48B4-9502-DD18BCEBCFE4Q39643651-B4F886D0-EE12-4EBB-B390-4C9ECBD4A1C4Q40162458-051E9304-1997-4076-89C8-C231F86E0428Q43477917-6F3BD8C3-4975-4957-A054-248233181D15Q44907684-D8B8AB8B-E1BA-4781-93F5-B6EAE2ABFAC5Q47201451-091A278A-98F4-48FC-9491-0FC60D6F7B96Q47659460-2C6AF35D-BCC9-4A95-AC11-53D9255C697AQ47950844-D2E82100-DCD7-48B7-9AC5-748D14A67AC6Q48005475-20D3D1B5-D33F-4C64-841F-C8F769382E9FQ48192208-D26079AD-6548-4880-A0E4-4AD60E727E2BQ48823410-19C1C5B7-8F3E-4BF6-B8F1-534E211006CAQ51515487-4889A732-7C8B-46D9-8389-8FF36BB06990Q54856088-C4F9FE58-0152-457B-BA75-EA445D2233EBQ55452474-D3D69A20-8ABB-4C64-9963-3B9CE7CD01A2Q57711517-ECD7C5FC-B1DA-446F-8BB5-A50523397D53
P2860
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Construction and validation of ...... he CaMos and Manitoba cohorts.
@en
Construction and validation of ...... he CaMos and Manitoba cohorts.
@nl
type
label
Construction and validation of ...... he CaMos and Manitoba cohorts.
@en
Construction and validation of ...... he CaMos and Manitoba cohorts.
@nl
prefLabel
Construction and validation of ...... he CaMos and Manitoba cohorts.
@en
Construction and validation of ...... he CaMos and Manitoba cohorts.
@nl
P2093
P2860
P1476
Construction and validation of ...... the CaMos and Manitoba cohorts
@en
P2093
C S Kovacs
Canadian Multicentre Osteoporosis Study Research Group
D A Hanley
D Goltzman
G Ioannidis
J D Adachi
P2860
P2888
P304
P356
10.1007/S00198-010-1445-5
P407
P577
2010-10-22T00:00:00Z